Hanmi receives tentative FDA approval for incrementally modified Nexium capsules

Published: 2013-05-07 07:00:00
Updated: 2013-05-07 07:00:00
Hanmi Pharmaceutical said Sunday that the U.S. Food and Drug Administration has recently granted tentative approval to the company's New Drug Application (NDA) for esomeprazole strontium delayed-release capsules.

Hanmi’s NDA was filed with the U.S. FDA including comparative bioequivalence te...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.